These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Neuromuscular pharmacodynamics of rocuronium in patients with major burns. Han T; Kim H; Bae J; Kim K; Martyn JA Anesth Analg; 2004 Aug; 99(2):386-92, table of contents. PubMed ID: 15271712 [TBL] [Abstract][Full Text] [Related]
23. The effects of major burn related pathophysiological changes on the pharmacokinetics and pharmacodynamics of drug use: An appraisal utilizing antibiotics. Udy AA; Roberts JA; Lipman J; Blot S Adv Drug Deliv Rev; 2018 Jan; 123():65-74. PubMed ID: 28964882 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation. Nang SC; Lin YW; Petrovic Fabijan A; Chang RYK; Rao GG; Iredell J; Chan HK; Li J Clin Microbiol Infect; 2023 Jun; 29(6):702-709. PubMed ID: 36736661 [TBL] [Abstract][Full Text] [Related]
25. Determination of Optimal Amikacin Dosing Regimens for Pediatric Patients With Burn Wound Sepsis. Yu T; Stockmann C; Healy DP; Olson J; Wead S; Neely AN; Kagan RJ; Spigarelli MG; Sherwin CM J Burn Care Res; 2015; 36(4):e244-52. PubMed ID: 25185930 [TBL] [Abstract][Full Text] [Related]
30. Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents. Asín-Prieto E; Rodríguez-Gascón A; Isla A J Infect Chemother; 2015 May; 21(5):319-29. PubMed ID: 25737147 [TBL] [Abstract][Full Text] [Related]
31. [Pharmacologic innovations, the fluoroquinolone model]. Bergogne-Bérézin E Presse Med; 2003 Mar; 32(10):466-9. PubMed ID: 12733312 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and pharmacodynamics of antimicrobial drugs in intensive care unit patients. Macedo RS; Onita JH; Wille MP; Furtado GH Shock; 2013 May; 39 Suppl 1():24-8. PubMed ID: 23481498 [TBL] [Abstract][Full Text] [Related]
33. Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest. Lees P; Landoni MF; Giraudel J; Toutain PL J Vet Pharmacol Ther; 2004 Dec; 27(6):479-90. PubMed ID: 15601442 [TBL] [Abstract][Full Text] [Related]
34. Cisatracurium pharmacokinetics and pharmacodynamics during hypothermic cardiopulmonary bypass in infants and children. Withington D; Ménard G; Varin F Paediatr Anaesth; 2011 Mar; 21(3):341-6. PubMed ID: 21223452 [TBL] [Abstract][Full Text] [Related]
35. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling. Meibohm B; Derendorf H Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388 [TBL] [Abstract][Full Text] [Related]
36. Microdialysis for pharmacokinetic-pharmacodynamic studies. Yu W; Cheng Q; Feng J; Li F Pharmazie; 2007 Dec; 62(12):883-91. PubMed ID: 18214337 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and pharmacodynamics of antimicrobial drugs. Czock D; Markert C; Hartman B; Keller F Expert Opin Drug Metab Toxicol; 2009 May; 5(5):475-87. PubMed ID: 19416084 [TBL] [Abstract][Full Text] [Related]
38. Current Aspects of Pediatric Pharmacokinetics and Pharmacodynamics of Antimicrobials in Japan: Importance of the Promotion of Population PK/PD Analysis. Shoji K; Saito J; Nakamura H; Matsumoto K; Oda K; Takesue Y; Miyairi I Pediatr Infect Dis J; 2022 Oct; 41(10):e418-e423. PubMed ID: 35763684 [TBL] [Abstract][Full Text] [Related]
39. Simultaneous versus sequential pharmacokinetic-pharmacodynamic population analysis using an iterative two-stage Bayesian technique. Proost JH; Schiere S; Eleveld DJ; Wierda JM Biopharm Drug Dispos; 2007 Nov; 28(8):455-73. PubMed ID: 17847121 [TBL] [Abstract][Full Text] [Related]
40. Methodology and applicability of the human contact burn injury model: A systematic review. Springborg AD; Wessel CR; Andersen LPK; Werner MU PLoS One; 2021; 16(7):e0254790. PubMed ID: 34329326 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]